ArticleCancer gene therapy2020

HITM-SIR: phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy and selective internal radiation therapy for CEA

Steven C Katz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.